129
Participants
Start Date
June 1, 2020
Primary Completion Date
February 15, 2022
Study Completion Date
February 15, 2022
convalescent plasma
The study will be interrupted if the efficacy of the convalescent plasma group is proven, so that all severely ill patients as defined in the study can receive the convalescent plasma treatment. The same will occur if there is no difference in primary outcome with the use of convalescent plasma or serious adverse effects.
University of Sao Paulo - General Hospital, São Paulo
Ministério da Ciência, Tecnologia, Inovações e Comunicações
UNKNOWN
Faculty of Medicine of Ribeirão Preto (FMRP-USP)
OTHER
Hospital de Clínicas, Faculdade de Medicina Universidade Estadual de Campinas
UNKNOWN
Hospital Sirio-Libanes
OTHER
Hospital Israelita Albert Einstein
OTHER
Grupo Hospitalar Conceição
OTHER_GOV
Hospital Ernesto Dornelles
OTHER
University of Sao Paulo General Hospital
OTHER